Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | DGKA | P23743 | 1/20 | 0.45 |
| ▸ | TLR4 | O00206 | 4/20 | 0.45 |
| ▸ | NAAA | Q02083 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | PAM | P19021 | 2/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.41 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 1/20 | 0.41 |
| ▸ | LY96 | Q9Y6Y9 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7754920 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL15656359 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL15656361 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL15660310 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL15659489 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL15659490 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL15659187 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL19304981 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL15660313 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 | |
| SCHEMBL8064456 | 1.00 | MAPT (0.61) | MAPTDGKATLR4NAAACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1086112-A2 | 1-GALACTOSE DERIVATIVES | SYNSORB Biotech Inc. (CA) | 2001-03-28 | — | — | EP | disclosed |
| US-6174867-B1 | INHIBITION OF THE BINDING OF A TOXIN OR ORGANISM TO ITS CORRESPONDING CELL SURFACE RECEPTOR; E.G., HEAT-LABILE ENTEROTOXIN OR CHOLERA TOXIN OR ENTEROVIRULENT ORGANISMS; BACTERICIDES, VIRICIDES, FUNGICIDES | SYNSORB BIOTECH, INC. (CA) | 2001-01-16 | — | — | US | disclosed |
| WO-1999058540-A2 | 1-GALACTOSE DERIVATIVES | SYNSORB BIOTECH, INC. (CA) | 1999-11-18 | — | — | WO | disclosed |
| EP-0939760-A2 | 1-THIOGALACTOSE DERIVATIVES | SYNSORB Biotech Inc. (CA) | 1999-09-08 | — | — | EP | disclosed |
| WO-1998021221-A2 | 1-THIOGALACTOSE DERIVATIVES | SYNSORB BIOTECH, INC. (CA) | 1998-05-22 | — | — | WO | disclosed |